Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (6) 6
science & technology (6) 6
female (5) 5
humans (5) 5
male (5) 5
obesity (5) 5
body mass index (4) 4
obesity - drug therapy (4) 4
risk factors (4) 4
adult (3) 3
double-blind method (3) 3
internal medicine (3) 3
middle aged (3) 3
weight loss (3) 3
weight loss - drug effects (3) 3
abridged index medicus (2) 2
adolescent (2) 2
body weight - drug effects (2) 2
body weight loss (2) 2
cardiology (2) 2
child (2) 2
clinical trials (2) 2
diabetes mellitus (2) 2
endocrinology (2) 2
evidence-based medicine (2) 2
exercise (2) 2
food and nutrition (2) 2
general & internal medicine (2) 2
glucagon-like peptide 1 - analogs & derivatives (2) 2
human health and pathology (2) 2
hypertension (2) 2
hypoglycemic agents - administration & dosage (2) 2
hypoglycemic agents - adverse effects (2) 2
injections, subcutaneous (2) 2
life sciences (2) 2
liraglutide - administration & dosage (2) 2
liraglutide - adverse effects (2) 2
liraglutide - pharmacology (2) 2
medicine (2) 2
medicine & public health (2) 2
medicine, general & internal (2) 2
obesity - epidemiology (2) 2
obesity - ethnology (2) 2
oncology (2) 2
pharmacology/toxicology (2) 2
rheumatology (2) 2
weight control (2) 2
adult; blood glucose; body mass index; combined modality therapy; counseling; diarrhea; diet, reducing; double-blind method; exercise; female; glucagon-like peptide 1; humans; hypoglycemic agents; injections, subcutaneous; liraglutide; male; middle aged; nausea; obesity; weight loss; medicine (1) 1
alcohol (1) 1
analysis (1) 1
anthropometry (1) 1
appetite depressants - adverse effects (1) 1
appetite depressants - therapeutic use (1) 1
autoimmune diseases (1) 1
back pain (1) 1
biological and medical sciences (1) 1
blood glucose (1) 1
blood glucose - analysis (1) 1
blood glucose - drug effects (1) 1
blood glucose - metabolism (1) 1
blood pressure - drug effects (1) 1
body fat (1) 1
body height - physiology (1) 1
body weight (1) 1
body weight - physiology (1) 1
bolivia (1) 1
cardiac arrest (1) 1
cardiovascular diseases (1) 1
cardiovascular risk factors (1) 1
charts (1) 1
children & youth (1) 1
classification (1) 1
clinical medicine (1) 1
combined modality therapy (1) 1
comorbidity (1) 1
counseling (1) 1
cross-sectional studies (1) 1
cyclobutanes - adverse effects (1) 1
cyclobutanes - therapeutic use (1) 1
demographic aspects (1) 1
diabetes (1) 1
diabetes mellitus, type 2 - diagnosis (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diabetes therapy (1) 1
diagnosis (1) 1
diarrhea (1) 1
diarrhea - chemically induced (1) 1
diet, reducing (1) 1
dosage and administration (1) 1
drug therapy (1) 1
dyslipidemia (1) 1
endocrinology & metabolism (1) 1
evaluation (1) 1
folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (1) 1
gallbladder diseases (1) 1
gastrointestinal surgery (1) 1
glucagon (1) 1
glucagon-like peptide 1 (1) 1
glucagon-like peptide 1 - administration & dosage (1) 1
glucagon-like peptide 1 - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
by Pi-Sunyer, Xavier and Astrup, Arne and Fujioka, Ken and Greenway, Frank and Halpern, Alfredo and Krempf, Michel and Lau, David C.W and le Roux, Carel W and Violante Ortiz, Rafael and Jensen, Christine Bjørn and Wilding, John P.H and SCALE Obesity Prediabet NN8022-183 and SCALE Obesity and Prediabetes NN8022-1839 Study Group
The New England journal of medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 1, pp. 11 - 22
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Body Mass Index | Blood Glucose - analysis | Double-Blind Method | Glucagon-Like Peptide 1 - administration & dosage | Nausea - chemically induced | Obesity - drug therapy | Glucagon-Like Peptide 1 - analogs & derivatives | Humans | Middle Aged | Male | Combined Modality Therapy | Weight Loss - drug effects | Diarrhea - chemically induced | Diet, Reducing | Exercise | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Counseling | Obesity - therapy | Adult | Female | Glucagon-Like Peptide 1 - adverse effects | Hypoglycemic Agents - adverse effects | Liraglutide | Overweight persons | Safety and security measures | Analysis | Cardiac arrest | Dosage and administration | Health aspects | Risk factors | Quality of life | Obesity | Glucagon | Diabetes mellitus | Body weight | Dyslipidemia | Diarrhea | Clinical trials | Nausea | Body weight loss | Evidence-based medicine | Weight control | Drug therapy | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Food and Nutrition
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
by le Roux, Carel W, Prof and Astrup, Arne, Prof and Fujioka, Ken, MD and Greenway, Frank, Prof and Lau, David C W, Prof and Van Gaal, Luc, Prof and Ortiz, Rafael Violante, MD and Wilding, John P H, Prof and Skjøth, Trine V, MD and Manning, Linda Shapiro, MD and Pi-Sunyer, Xavier, Prof and SCALE Obesity Prediabetes NN8022-1839 Study Group and SCALE Obesity & Prediabet NN8022
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10077, pp. 1399 - 1409
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Obesity - drug therapy | Glucagon-Like Peptide-1 Receptor - administration & dosage | Humans | Middle Aged | Body Weight - drug effects | Male | Weight Loss - drug effects | Liraglutide - pharmacology | Injections, Subcutaneous | Adult | Female | Placebos - administration & dosage | Body Mass Index | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Risk Reduction Behavior | Glucagon-Like Peptide 1 - analogs & derivatives | Obesity - complications | Glucagon-Like Peptide 1 - pharmacology | Prediabetic State - prevention & control | Treatment Outcome | Prediabetic State - complications | Blood Glucose - drug effects | Prediabetic State - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Liraglutide - adverse effects | Obesity - epidemiology | Placebos - pharmacology | Incretins - therapeutic use | Liraglutide - administration & dosage | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Glucagon-Like Peptide-1 Receptor - agonists | Type 2 diabetes | Clinical trials | Glucose metabolism | Risk factors | Prediabetic state | Diabetes therapy | Exercise | Obesity | Evaluation | Diabetes mellitus | Health risks | Weight loss | Glucose | Evidence-based medicine | Studies | Weight control | Randomization | Immunology | Classification | Weight reduction | Gastrointestinal surgery | Diabetes | Clinical medicine | Diagnosis | Autoimmune diseases | Risk management | Back pain | Physical activity | Gallbladder diseases | Body weight loss | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Hypertension | Risk reduction | Metabolism | Investigations | Nutrition research | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Effects of liraglutide 3.0 mg on weight and risk factors in hispanic versus non-hipanic populations: Subgroup analysis from scale randomized trials
by O'Neil, Patrick M and Garvey, W. Timothy and Gonzalez-Campoy, J. Michael and Mora, Pablo and Ortiz, Rafael Violante and Guerrero, German and Claudius, Birgitte and Pi-Sunyer, Xavier and Satiety and Clinical Adiposity – Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups
Endocrine practice, ISSN 1530-891X, 11/2016, Volume 22, Issue 11, pp. 1277 - 1287
Double-Blind Method | Obesity - drug therapy | Comorbidity | Overweight - drug therapy | Humans | Middle Aged | Risk Factors | Hispanic Americans | Obesity - ethnology | Male | Weight Loss - drug effects | Hypoglycemic Agents - pharmacology | Hypoglycemic Agents - administration & dosage | Liraglutide - adverse effects | Liraglutide - pharmacology | Adult | Female | Overweight - ethnology | Liraglutide - administration & dosage | Outcome Assessment, Health Care | Hypoglycemic Agents - adverse effects
Journal Article
Details down arrow
4. Full Text Use of sibutramine in obese hispanic adolescents
by Violante-Ortíz, Rafael and Del-Rio-Navarro, Blanca Estela and Lara-Esqueda, Agustín and Pérez, Pedro and Fanghänel, Guillermo and Madero, Agustín and Berber, Arturo
Advances in therapy, ISSN 0741-238X, 11/2005, Volume 22, Issue 6, pp. 642 - 649
sibutramine | Medicine & Public Health | Rheumatology | weight loss | Internal Medicine | Oncology | adolescent | Cardiology | Pharmacology/Toxicology | Endocrinology | obesity | Obesity | Sibutramine | Adolescent | Weight loss | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Body Mass Index | Appetite Depressants - adverse effects | Cyclobutanes - adverse effects | Cyclobutanes - therapeutic use | Obesity - drug therapy | Humans | Body Weight - drug effects | Male | Appetite Depressants - therapeutic use | Heart Rate - drug effects | Female | Mexico | Blood Pressure - drug effects | Child | Health technology assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Mexican anthropometric percentiles for ages 10-18
by Del-Rio-Navarro, B.E and Velazquez-Monroy, O and Santos-Preciado, J.I and Lara-Esqueda, A and Berber, A and Loredo-Abdala, A and Violante-Ortiz, R and Tapia-Conyer, R
European journal of clinical nutrition, ISSN 0954-3007, 08/2007, Volume 61, Issue 8, pp. 963 - 975
Life Sciences & Biomedicine | Nutrition & Dietetics | Science & Technology | Obesity | Biological and medical sciences | Metabolic diseases | Medical sciences | Body Height - physiology | Body Mass Index | Rural Population - statistics & numerical data | Urban Population - statistics & numerical data | Cross-Sectional Studies | Mexico - epidemiology | Anthropometry | Humans | Obesity - ethnology | Male | Reference Values | Overweight | Growth - physiology | Obesity - epidemiology | Adolescent | Female | Obesity - diagnosis | Body Weight - physiology | Child | Charts | Height | Body fat | Human growth | Children & youth | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HISPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS
by O'Neil, Patrick M and Garvey, W. Timothy and Gonzalez-Campoy, J. Michael and Mora, Pablo and Ortiz, Rafael Violante and Guerrero, German and Claudius, Birgitte and Pi-Sunyer, Xavier and Satiety Clin Adiposity Liraglutide
Endocrine practice, ISSN 1530-891X, 11/2016, Volume 22, Issue 11, pp. 1277 - 1287
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology
Journal Article
Details down arrow
7. Full Text Letter to the editor
by Bastarrachea, Raul A and López-Alvarenga, Juan C and Calzada-León, Raúl and Arellano-Montaño, Sara and Gonzalez-Barranco, Jorge and Violante-Ortíz, Rafael and Del-Rio-Navarro, Blanca Estela and Lara-Esqueda, Agustín and Pérez, Pedro and Fanghänel, Guillermo and Madero, Agustín and Berber, Arturo
Advances in therapy, ISSN 0741-238X, 5/2006, Volume 23, Issue 3, pp. 506 - 509
Medicine & Public Health | Rheumatology | Internal Medicine | Oncology | Cardiology | Pharmacology/Toxicology | Endocrinology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prevalence and determinants of cardiovascular disease risk factors using the WHO STEPS approach in Cochabamba, Bolivia
by Mamani-Ortiz, Yercin and San Sebastián, Miguel and Armaza, Ada X and Luizaga, Jenny M and Illanes, Daniel E and Ferrel, Marcia and Mosquera, Paola A
BMC public health, ISSN 1471-2458, 06/2019, Volume 19, Issue 1, pp. 786 - 786
Hypertension | Obesity | Tobacco | Cardiovascular risk factors | Alcohol | Bolivia | WHO STEPS approach | Life Sciences & Biomedicine | Public, Environmental & Occupational Health | Science & Technology | Demographic aspects | Cardiovascular diseases | Risk factors | Prevalence studies (Epidemiology) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.